This inventor holds 1 USPTO granted patent. Top assignee: Ghc Research Development Corporation. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Innovations in Cancer Therapy by Jang P Park
Introduction: Jang P Park is an accomplished inventor based in Greenville, SC (US). He has made significant contributions to the field of cancer therapy through his innovative research and development efforts. His work focuses on novel approaches to combat cancer, particularly through the use of VEGF receptor antagonists.
Latest Patents: Jang P Park holds a patent for VEGF receptor antagonists. The present invention describes an approach to cancer therapy utilizing these novel antagonists. Specifically, the invention provides peptides and polynucleotides encoding VEGF receptor antagonists and methods of use thereof. This patent represents a crucial advancement in the fight against cancer.
Career Highlights: Jang P Park is associated with Ghc Research Development Corporation, where he continues to work on groundbreaking research. His dedication to innovation in cancer therapy has positioned him as a key figure in the field. With a focus on developing effective treatments, he has contributed to the advancement of medical science.
Collaborations: Jang P Park collaborates with fellow researcher Wen Yuan Chen. Their combined expertise enhances the potential for developing effective cancer therapies.
Conclusion: Jang P Park's work in developing VEGF receptor antagonists showcases his commitment to advancing cancer treatment. His innovative approach and collaboration with other researchers highlight the importance of teamwork in scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile